275 related articles for article (PubMed ID: 10987261)
1. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.
Basso C; Thiene G; Corrado D; Buja G; Melacini P; Nava A
Hum Pathol; 2000 Aug; 31(8):988-98. PubMed ID: 10987261
[TBL] [Abstract][Full Text] [Related]
2. Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death.
Yetman AT; McCrindle BW; MacDonald C; Freedom RM; Gow R
N Engl J Med; 1998 Oct; 339(17):1201-9. PubMed ID: 9780340
[TBL] [Abstract][Full Text] [Related]
3. Morphologic features of exertional versus nonexertional sudden death in patients with hypertrophic cardiomyopathy.
Tavora F; Cresswell N; Li L; Ripple M; Fowler D; Burke A
Am J Cardiol; 2010 Feb; 105(4):532-7. PubMed ID: 20152250
[TBL] [Abstract][Full Text] [Related]
4. Morphologic evidence for "small vessel disease" in patients with hypertrophic cardiomyopathy.
Maron BJ; Wolfson JK; Epstein SE; Roberts WC
Z Kardiol; 1987; 76 Suppl 3():91-100. PubMed ID: 3433879
[TBL] [Abstract][Full Text] [Related]
5. Sudden death in young athletes.
Tsung SH; Huang TY; Chang HH
Arch Pathol Lab Med; 1982 Apr; 106(4):168-70. PubMed ID: 6461311
[TBL] [Abstract][Full Text] [Related]
6. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
Basso C; Thiene G; Mackey-Bojack S; Frigo AC; Corrado D; Maron BJ
Eur Heart J; 2009 Jul; 30(13):1627-34. PubMed ID: 19406869
[TBL] [Abstract][Full Text] [Related]
7. [Hypertrophic cardiomyopathy: mode of death and pathological findings].
Fujiwara H; Tanaka M; Onodera T; Kawai C
J Cardiol Suppl; 1987; 16():3-8. PubMed ID: 3509681
[TBL] [Abstract][Full Text] [Related]
8. [Myocardial disease mortality in children and young adults. A population-based observational study].
Morentin B; Suárez-Mier MP; Aguilera B; Bodegas A
Rev Esp Cardiol; 2006 Mar; 59(3):238-46. PubMed ID: 16712748
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic heterogeneity in hypertrophic cardiomyopathy with regard to age, asymmetric septal hypertrophy, and concentric hypertrophy beyond the pediatric age group.
Litovsky SH; Rose AG
Arch Pathol Lab Med; 1998 May; 122(5):434-41. PubMed ID: 9593345
[TBL] [Abstract][Full Text] [Related]
10. [Dysplastic intramyocardial arteries with subaortic septum in patients with hypertrophic obstructive cardiomyopathy].
Schwartzkopff B; Dieckerhoff J; Frenzel H; Schulte HD; Lösse B; Motz W; Hort W; Strauer BE
Z Kardiol; 1992 Aug; 81(8):456-63. PubMed ID: 1413956
[TBL] [Abstract][Full Text] [Related]
11. [Relation between disorders of cardiac rhythm to the symptomatology and extent of hypertrophic cardiomyopathy].
Gregor P; Widimský P; Kohout P; Sochor K; Bufka V; Cervenka V; Vísek V
Vnitr Lek; 1989 Jul; 35(7):632-8. PubMed ID: 2800367
[TBL] [Abstract][Full Text] [Related]
12. Cardiac inflammatory myofibroblastic tumor: a "benign" neoplasm that may result in syncope, myocardial infarction, and sudden death.
Burke A; Li L; Kling E; Kutys R; Virmani R; Miettinen M
Am J Surg Pathol; 2007 Jul; 31(7):1115-22. PubMed ID: 17592279
[TBL] [Abstract][Full Text] [Related]
13. [Natural history of hypertrophic obstructive cardiomyopathy in young patients: apropos of 40 cases].
Azzano O; Bozio A; Sassolas F; Di Filippo S; Agé C; André M; Jocteur-Monrozier D; Normand J
Arch Mal Coeur Vaiss; 1995 May; 88(5):667-72. PubMed ID: 7646275
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms.
Schumacher B; Gietzen FH; Neuser H; Schümmelfeder J; Schneider M; Kerber S; Schimpf R; Wolpert C; Borggrefe M
Circulation; 2005 Oct; 112(14):2096-101. PubMed ID: 16186424
[TBL] [Abstract][Full Text] [Related]
15. [Hypertrophic cardiomyopathy and juvenile sudden death. A clinical case and re-evaluation of the problem].
Corrado D; Carraro R; Buja G; Fasoli G; Thiene G
G Ital Cardiol; 1986 Dec; 16(12):1002-8. PubMed ID: 3556936
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
17. Comparison of percentage area of myocardial fibrosis and disarray in patients with classical form and dilated phase of hypertrophic cardiomyopathy.
Iida K; Yutani C; Imakita M; Ishibashi-Ueda H
J Cardiol; 1998 Sep; 32(3):173-80. PubMed ID: 9783238
[TBL] [Abstract][Full Text] [Related]
18. [Pathological study of unexpected sudden death clustered in family or village in Yunnan province: report of 29 cases of autopsy].
Wang HY; Zhao H; Song LF; Huang WL; Niu CL; Li ZX; Yang CF; Liu XB; Liu JH; Yang L; Zhao S; Ren JM; Shi GQ; Zhang J; Pu JL; Yang YJ; Zeng G
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(31):2209-14. PubMed ID: 18001532
[TBL] [Abstract][Full Text] [Related]
19. Sudden death associated with anomalous coronary origin and obstructive coronary disease in the young.
Eckart RE; Jones SO; Shry EA; Garrett PD; Scoville SL
Cardiol Rev; 2006; 14(4):161-3. PubMed ID: 16788326
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy: an autopsy analysis of 14 cases.
Phadke RS; Vaideeswar P; Mittal B; Deshpande J
J Postgrad Med; 2001; 47(3):165-70. PubMed ID: 11832616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
